Related references
Note: Only part of the references are listed.Structural Analysis of Asunaprevir Resistance in HCV NS3/4A Protease
Djade I. Soumana et al.
ACS CHEMICAL BIOLOGY (2014)
Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease
Ye Yu et al.
ACTA PHARMACOLOGICA SINICA (2014)
Polymerases of hepatitis C viruses and flaviviruses: Structural and mechanistic insights and drug development
Celia Caillet-Saguy et al.
ANTIVIRAL RESEARCH (2014)
Antiviral therapy of hepatitis C in 2014: Do we need resistance testing?
Maximilian David Schneider et al.
ANTIVIRAL RESEARCH (2014)
Cost-Effectiveness of Sofosbuvir-Based Triple Therapy for Untreated Patients With Genotype 1 Chronic Hepatitis C
Salvatore Petta et al.
HEPATOLOGY (2014)
Global epidemiology and genotype distribution of the hepatitis C virus infection
Erin Gower et al.
JOURNAL OF HEPATOLOGY (2014)
Daclatasvir plus sofosbuvir for HCV infection: An oral combination therapy with high antiviral efficacy
Tarik Asselah
JOURNAL OF HEPATOLOGY (2014)
Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor
Asa Rosenquist et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Sofosbuvir: A novel treatment option for chronic hepatitis C infection
Harmeet Kaur Bhatia et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2014)
Telaprevir to Boceprevir Switch Highlights Lack of Cross-Reactivity
Amanda Carlson et al.
CLINICAL INFECTIOUS DISEASES (2013)
The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir
Kristen M. Marks et al.
ANTIVIRAL THERAPY (2012)
Hepatitis C RNA-dependent RNA polymerase inhibitors: A review of structure-activity and resistance relationships; different scaffolds and mutations
Abdelrahman S. Mayhoub
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1
Hussin A. Rothan et al.
BMC INFECTIOUS DISEASES (2012)
High Affinity Peptide Inhibitors of the Hepatitis C Virus NS3-4A Protease Refractory to Common Resistant Mutants
Jonas Kuegler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Protegrin-1 Inhibits Dengue NS2B-NS3 Serine Protease and Viral Replication in MK2 Cells
Hussin A. Rothan et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
WeNMR: Structural Biology on the Grid
Tsjerk A. Wassenaar et al.
JOURNAL OF GRID COMPUTING (2012)
Activation of the Ras/Raf/MEK Pathway Facilitates Hepatitis C Virus Replication via Attenuation of the Interferon-JAK-STAT Pathway
Qi Zhang et al.
JOURNAL OF VIROLOGY (2012)
Current progress in the treatment of chronic hepatitis C
Alexandra Alexopoulou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
Keith P. Romano et al.
PLOS PATHOGENS (2012)
Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype I infection
Kristian Thorlund et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2012)
Evolving epidemiology of hepatitis C virus
D. Lavanchy
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus
K. Morikawa et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Expression of plectasin in Pichia pastoris and its characterization as a new antimicrobial peptide against Staphyloccocus and Streptococcus
Jun Zhang et al.
PROTEIN EXPRESSION AND PURIFICATION (2011)
An overview of HCV molecular biology, replication and immune responses
Usman A. Ashfaq et al.
VIROLOGY JOURNAL (2011)
Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro
Qing-long Liang et al.
BIOTECHNOLOGY LETTERS (2010)
Hepatitis C Virus Non-structural Protein 3 (HCV NS3): A Multifunctional Antiviral Target
Kevin D. Raney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The HADDOCK web server for data-driven biomolecular docking
Sjoerd J. De Vries et al.
NATURE PROTOCOLS (2010)
Influence of Antidrug Antibodies on Plectasin Efficacy and Pharmacokinetics
Karoline Sidelmann Brinch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Racemic crystallography of synthetic protein enantiomers used to determine the X-ray structure of plectasin by direct methods
Kalyaneswar Mandal et al.
PROTEIN SCIENCE (2009)
NS3 peptide, a novel potent hepatitis C virus NS3 helicase inhibitor:: Its mechanism of action and antiviral activity in the replicon system
Agnieszka Gozdek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
PH Mygind et al.
NATURE (2005)
Genetic diversity and evolution of hepatitis C virus - 15 years on
P Simmonds
JOURNAL OF GENERAL VIROLOGY (2004)
Increasing the precision of comparative models with YASARA NOVA - a self-parameterizing force field
E Krieger et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2002)
Inhibition of the hepatitis C virus NS3/4A protease - The crystal structures of two protease-inhibitor complexes
S Di Marco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
